12:12 IST
BSE
Annual Report
Anthem Biosciences Annual Report
Anthem Biosciences sent shareholders a letter with a web link and exact path to access its FY 2025‑26 annual report. The notice meets SEBI Regulation 36(1)(b).
Anthem Biosciences Ltd
- Share price
- ₹885.85
- Market cap
- ₹49,891 Cr
- Revenue (annual)
- ₹2,124 Cr
- Net profit (annual)
- ₹591.8 Cr
- P/E (TTM)
- 86.6×Sector 47.4×
- Promoter holding
- 71.42%-3.26% QoQ
- FII holding
- 2.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Other Announcement 3Financial Results 3Results Update 2Business Update 2Board Meeting Outcome 2Board Meeting Date 2Annual Report 2Annual General Meeting 2Results Correction 1Management Change 1Legal & Regulatory 1Employee Stock Options 1Dividend 1Debt & Borrowing 1Credit Rating 1
Time
2 announcements with these filters
22:25 IST
BSE
Annual Report
Anthem Biosciences Annual Report
Anthem Biosciences Limited filed its Annual Report for FY 2025-26. The report includes key highlights and operational journeys.